The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder

SALT LAKE CITY, Nov. 04, 2016 -- (Healthcare Sales & Marketing Network) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (MYGN), today announced that a poster featuring the GeneSight® test will be presented at the Neuroscience Educ... Diagnostics, Personalized Medicine Assurex Health, Myriad Genetics, GeneSight, generalized anxiety disorder
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news